Causality of genetically determined glucosamine supplementation on cognition and sarcopenia: a Mendelian randomization study
2024

Glucosamine and Its Effects on Cognition and Sarcopenia

publication 10 minutes Evidence: moderate

Author Information

Author(s): Kang Yi, Tang Yidan, Kong Weishuang, Zhu Tao, Chen Guo

Primary Institution: West China Hospital, Sichuan University, Chengdu, China

Hypothesis

Regular glucosamine use may causally impact cognition and sarcopenia-related traits.

Conclusion

Regular glucosamine use enhances cognitive function and postpones sarcopenia.

Supporting Evidence

  • Glucosamine was associated with increased cognitive performance and fluid intelligence score.
  • Glucosamine use was linked to higher appendicular lean mass and whole body fat-free mass.
  • Regular glucosamine use was associated with improved physical activity levels.

Takeaway

Taking glucosamine can help your brain work better and keep your muscles strong as you get older.

Methodology

Mendelian randomization analysis using genetic variants linked to glucosamine.

Potential Biases

Potential confounding factors related to glucosamine use and its effects.

Limitations

The study's findings may not be generalizable to non-European populations.

Participant Demographics

Primarily European ancestry participants.

Statistical Information

P-Value

8.46E-04

Confidence Interval

95% CI = 1.15-1.70

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fendo.2024.1404308

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication